Mineralys Therapeutics
MLYS
#6796
Rank
$0.51 B
Marketcap
$10.30
Share price
0.29%
Change (1 day)
-15.30%
Change (1 year)

Mineralys Therapeutics (MLYS) - Total debt

Total debt on the balance sheet as of September 2024 : N/A

According to Mineralys Therapeutics's latest financial reports the company's total debt is N/A. A companyโ€™s total debt is the sum of all current and non-current debts.

Mineralys Therapeutics - Total debt on balance sheet (in 2020)

Total debt by year

Year Total debt Change
2020-12-31$4.5 M